The Midside Tape
The Midday Tape
The S&P is grinding higher into midday on a labor print that came in firm, but the real action is underneath the index, where a memory-chip bid is rotating money out of Apple (AAPL) and into semis ahead of tonight's heaviest earnings slate of the quarter.
Labor data holds, yields tick up.
JOLTS job openings printed at 7.523 million and factory orders rose 1.8%, both readings firm enough to keep the "no hard landing" narrative intact. Treasuries are softer on the print, with the long bond (TLT) down half a percent, while the dollar (UUP) sits flat. Equities are shrugging it off: the S&P 500 (SPY) is up 0.6%, the Nasdaq (QQQ) up 1%, and the Russell 2000 (IWM) up 0.9%, broad enough participation to call this risk-on rather than a narrow mega-cap melt-up.
Memory stocks bounce, Apple pays the price.
The session's defining trade is the memory complex. Reports framing Micron's pricing power as a direct hit to Apple's margins have memory names bouncing while Apple slides 2.8%, even after UBS nudged its price target up to $340 on a Neutral rating, the upgrade doing nothing to stop the bleeding. Apple's name is also tangled in a fresh Spanish antitrust sanction alongside Amazon (AMZN) over distributor contract terms, though Amazon itself is barely moved, up 0.7%, suggesting the market is reading this as an Apple-specific margin story, not a platform-wide one.
AI trade stays bid into AMD.
Oracle (ORCL) is the standout, up 6%, riding the same AI-infrastructure enthusiasm that has traders positioning ahead of Advanced Micro Devices' results after the close, with chatter already circulating over what CEO Lisa Su will say about data-center demand alongside Nvidia, Meta, Microsoft, and TSMC. Separately, Sequoia's Shaun Maguire calling Amazon, Google, and Microsoft "absolute jokes" next to SpaceX is giving SpaceX-linked shares (SPCX) a lift, up over 4%, on the suggestion that the AI hyperscalers are underpricing a space and connectivity threat.
Housing and biotech take analyst hits.
Toll Brothers (TOL) is down 1.7% after Morgan Stanley trimmed its price target to $170, with KB Home catching a similar cut, a sign the homebuilder trade is getting squeezed even as the broader tape grinds higher. BioMarin (BMRN) is the session's biggest laggard among names we track, down 5.5% after both Wedbush and RBC cut price targets within the same hour. Axsome Therapeutics (AXSM) is bucking its own target cut, up 3.7% regardless.
Still ahead this afternoon:
AMD headlines the after-the-bell slate, joined by AIG, BioNTech, Shopify, Booking Holdings, Block, Toast, Duolingo, and Super Micro, a deluge that sets up the real test of whether this AI-led bid can hold into tomorrow.
Bottom line: the tape is broadly risk-on and firm, but leadership has rotated hard into chips and AI infrastructure at Apple's expense, and this afternoon's AMD print is the swing factor for whether that rotation extends or reverses.